These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 1438921)
21. Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Curnutte JT Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499 [TBL] [Abstract][Full Text] [Related]
22. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143 [TBL] [Abstract][Full Text] [Related]
25. [Chronic septic granulomatous disease in two brothers (author's transl)]. Rister M; Fröhlich G; Seiferth J Dtsch Med Wochenschr; 1974 Oct; 99(43):2172-5. PubMed ID: 4154190 [No Abstract] [Full Text] [Related]
26. Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood. Gallin JI Int J Tissue React; 1993; 15(3):99-103. PubMed ID: 8188451 [TBL] [Abstract][Full Text] [Related]
27. Lysosomal enzyme release from polymorphonuclear leukocytes in patients with chronic granulomatous disease: the effect of hydrogen peroxide on released enzyme activities. Kobayashi M; Tanaka T; Usui T Hiroshima J Med Sci; 1981 Dec; 30(4):339-44. PubMed ID: 6765683 [No Abstract] [Full Text] [Related]
28. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Roos D; de Boer M; Kuribayashi F; Meischl C; Weening RS; Segal AW; Ahlin A; Nemet K; Hossle JP; Bernatowska-Matuszkiewicz E; Middleton-Price H Blood; 1996 Mar; 87(5):1663-81. PubMed ID: 8634410 [No Abstract] [Full Text] [Related]
29. [Dysfunction of phagocytes--chronic granulomatous disease]. Kobayashi M; Usui T Rinsho Byori; 1985 Nov; 33(11):1217-23. PubMed ID: 4094101 [No Abstract] [Full Text] [Related]
30. Phagocytic NADPH oxidase and its role in chronic granulomatous disease. Pallister CJ; Hancock JT Br J Biomed Sci; 1995 Jun; 52(2):149-56. PubMed ID: 8520251 [TBL] [Abstract][Full Text] [Related]
31. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Bemiller LS; Roberts DH; Starko KM; Curnutte JT Blood Cells Mol Dis; 1995; 21(3):239-47. PubMed ID: 8673477 [TBL] [Abstract][Full Text] [Related]
32. Management of children on interferon therapy. Vitale MK; Willwerth-Fortin J; Robbins K Pediatr Nurs; 1993; 19(3):230-4. PubMed ID: 8511002 [TBL] [Abstract][Full Text] [Related]
33. Persistent pneumonia in a nine-month-old boy. Darden MD; Josephs SH Ann Allergy; 1983 Jul; 51(1 Pt 1):11-2, 35-7. PubMed ID: 6869931 [No Abstract] [Full Text] [Related]
34. [Intracellular enzymatic deficiencies as a basis of phagocytosis defects of neutrophils (author's transl)]. Lisiewicz J Przegl Lek; 1979; 36(8):617-21. PubMed ID: 228356 [No Abstract] [Full Text] [Related]
35. Deficiency of cytochrome b558 in chronic granulomatous disease demonstrated by monoclonal antibody 7D5. Nakamura M; Kobayashi S; Sendo S; Koga T; Kanegasaki S Acta Paediatr Hung; 1988-1989; 29(1-2):179-83. PubMed ID: 3255400 [No Abstract] [Full Text] [Related]
37. Structure of the NADPH-oxidase: membrane components. Segal AW Immunodeficiency; 1993; 4(1-4):167-79. PubMed ID: 8167695 [No Abstract] [Full Text] [Related]
38. Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. Clark RA; Klebanoff SJ J Immunol; 1980 Jan; 124(1):399-405. PubMed ID: 6243151 [No Abstract] [Full Text] [Related]
39. Different subcellular localization of cytochrome b and the dormant NADPH-oxidase in neutrophils and macrophages: effect on the production of reactive oxygen species during phagocytosis. Johansson A; Jesaitis AJ; Lundqvist H; Magnusson KE; Sjölin C; Karlsson A; Dahlgren C Cell Immunol; 1995 Mar; 161(1):61-71. PubMed ID: 7867086 [TBL] [Abstract][Full Text] [Related]